To view Atlas Arteria's acquisition of a majority interest in Chicago Skyway presentation please click here
For further information on Atlas Arteria's Retail Entitlement Offer please click here
Atlas Arteria interest (%)
As of 2 March 2020
EBITDA margin (%)
For the 12 months ended 31 December 2020
* ALX owns an estimated 100% economic interest in TRIP II LP, the owner of the concession for the Dulles Greenway. This interest is held through 86.6% subordinated loans and 13.4% equity interest.
Atlas Arteria (ALX) comprises Atlas Arteria Limited (ACN 141 075 201) (ATLAX) an Australian public company and Atlas Arteria International Limited (Registration No. 43828) (ATLIX), an exempted mutual fund company incorporated in Bermuda.
The information on this website has been prepared by ALX based on information available to them. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, none of ATLAX, ATLIX, their directors, employees or agents, nor any other person accepts any liability for any loss arising from the use of this website or its contents or otherwise arising in connection with it, including, without limitation, any liability arising from fault or negligence on the part of ATLAX, ATLIX, or their directors, employees or agents.
None of the information on this website should be reproduced or distributed to any other party without the consent of ALX.
General Securities Warning
The information on this website is a general description of ALX and is not an offer or invitation for subscription or purchase of or a recommendation of securities. If does not take into account the investment objectives, financial situation and particular needs of the investor. Before making an investment in ALX the investor or prospective investor should consider whether such an investment is appropriate to their particular investment needs, objectives and financial circumstances and seek professional independent advice.
All securities and financial product or instrument transactions involve risks. Past performance of ALX is not a reliable indication of future performance.
© Atlas Arteria™ (ALX)
Atlas Arteria (ALX) comprises Atlas Arteria Limited (ACN 141 075 201) (ATLAX) an Australian public company and Atlas Arteria International Limited (Registration No. 43828) (ATLIX), an exempted mutual fund company incorporated in Bermuda.
The information on this website has been prepared by ALX based on information available to them. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, none of ATLAX, ATLIX, their directors, employees or agents, nor any other person accepts any liability for any loss arising from the use of this website or its contents or otherwise arising in connection with it, including, without limitation, any liability arising from fault or negligence on the part of ATLAX, ATLIX, or their directors, employees or agents.
None of the information on this website should be reproduced or distributed to any other party without the consent of ALX.
General Securities Warning
The information on this website is a general description of ALX and is not an offer or invitation for subscription or purchase of or a recommendation of securities. If does not take into account the investment objectives, financial situation and particular needs of the investor. Before making an investment in ALX the investor or prospective investor should consider whether such an investment is appropriate to their particular investment needs, objectives and financial circumstances and seek professional independent advice.
All securities and financial product or instrument transactions involve risks. Past performance of ALX is not a reliable indication of future performance.
© Atlas Arteria™ (ALX)
Atlas Arteria (ALX) comprises Atlas Arteria Limited (ACN 141 075 201) (ATLAX) an Australian public company and Atlas Arteria International Limited (Registration No. 43828) (ATLIX), an exempted mutual fund company incorporated in Bermuda.
The information on this website has been prepared by ALX based on information available to them. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, none of ATLAX, ATLIX, their directors, employees or agents, nor any other person accepts any liability for any loss arising from the use of this website or its contents or otherwise arising in connection with it, including, without limitation, any liability arising from fault or negligence on the part of ATLAX, ATLIX, or their directors, employees or agents.
None of the information on this website should be reproduced or distributed to any other party without the consent of ALX.
General Securities Warning
The information on this website is a general description of ALX and is not an offer or invitation for subscription or purchase of or a recommendation of securities. If does not take into account the investment objectives, financial situation and particular needs of the investor. Before making an investment in ALX the investor or prospective investor should consider whether such an investment is appropriate to their particular investment needs, objectives and financial circumstances and seek professional independent advice.
All securities and financial product or instrument transactions involve risks. Past performance of ALX is not a reliable indication of future performance.
© Atlas Arteria™ (ALX)
